Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Yersinia Infections | 4 | 2025 | 7 | 1.440 |
Why?
|
| Yersinia pseudotuberculosis | 3 | 2025 | 6 | 1.270 |
Why?
|
| Yersinia pseudotuberculosis Infections | 2 | 2025 | 2 | 0.430 |
Why?
|
| Taste | 2 | 2024 | 28 | 0.430 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2025 | 642 | 0.360 |
Why?
|
| Anastomotic Leak | 1 | 2026 | 36 | 0.240 |
Why?
|
| Indoleacetic Acids | 1 | 2025 | 2 | 0.230 |
Why?
|
| Plant Tumors | 1 | 2025 | 3 | 0.230 |
Why?
|
| Plant Growth Regulators | 1 | 2025 | 9 | 0.230 |
Why?
|
| Basidiomycota | 1 | 2025 | 10 | 0.230 |
Why?
|
| Esophageal Atresia | 1 | 2026 | 53 | 0.230 |
Why?
|
| Poaceae | 1 | 2025 | 14 | 0.230 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2025 | 55 | 0.230 |
Why?
|
| Monocytes | 2 | 2024 | 335 | 0.220 |
Why?
|
| Odorants | 1 | 2024 | 64 | 0.210 |
Why?
|
| Yersinia | 1 | 2024 | 5 | 0.210 |
Why?
|
| Interleukins | 1 | 2025 | 122 | 0.210 |
Why?
|
| Intestines | 2 | 2025 | 591 | 0.210 |
Why?
|
| Clostridium Infections | 2 | 2025 | 248 | 0.210 |
Why?
|
| Taste Buds | 1 | 2023 | 3 | 0.210 |
Why?
|
| Interleukin-1 | 1 | 2024 | 129 | 0.200 |
Why?
|
| Lymphocytes | 1 | 2025 | 347 | 0.200 |
Why?
|
| C-Reactive Protein | 1 | 2026 | 450 | 0.200 |
Why?
|
| Neoplasm Metastasis | 1 | 2025 | 701 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 173 | 0.190 |
Why?
|
| Organoids | 1 | 2025 | 306 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2025 | 410 | 0.180 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2021 | 43 | 0.180 |
Why?
|
| Nerve Growth Factors | 1 | 2021 | 68 | 0.170 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 82 | 0.170 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 631 | 0.150 |
Why?
|
| Iron, Dietary | 1 | 2019 | 16 | 0.150 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2024 | 427 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2025 | 1087 | 0.140 |
Why?
|
| Stem Cells | 1 | 2023 | 711 | 0.140 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2019 | 26 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 2025 | 987 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 125 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2019 | 220 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 652 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 193 | 0.130 |
Why?
|
| Lung | 1 | 2024 | 1575 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2025 | 4665 | 0.120 |
Why?
|
| Autophagy | 1 | 2018 | 422 | 0.110 |
Why?
|
| Mice | 7 | 2025 | 18224 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 327 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2026 | 3114 | 0.100 |
Why?
|
| Animals | 9 | 2025 | 33899 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4701 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 744 | 0.090 |
Why?
|
| Cell Survival | 2 | 2023 | 840 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1791 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2026 | 248 | 0.060 |
Why?
|
| Physical Endurance | 1 | 2024 | 42 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3702 | 0.050 |
Why?
|
| Symbiosis | 1 | 2025 | 95 | 0.050 |
Why?
|
| Bicycling | 1 | 2024 | 35 | 0.050 |
Why?
|
| Perfusion Imaging | 1 | 2024 | 12 | 0.050 |
Why?
|
| ROC Curve | 1 | 2026 | 616 | 0.050 |
Why?
|
| Taste Perception | 1 | 2023 | 4 | 0.050 |
Why?
|
| Submandibular Gland | 1 | 2023 | 5 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2023 | 2468 | 0.050 |
Why?
|
| Smell | 1 | 2024 | 105 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2023 | 34 | 0.050 |
Why?
|
| Exercise Test | 1 | 2024 | 240 | 0.050 |
Why?
|
| Humans | 6 | 2026 | 130574 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 630 | 0.050 |
Why?
|
| Fatigue | 1 | 2024 | 195 | 0.050 |
Why?
|
| Imidazoles | 1 | 2025 | 219 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2024 | 328 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2023 | 77 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 1 | 2025 | 229 | 0.050 |
Why?
|
| Saliva | 1 | 2023 | 125 | 0.050 |
Why?
|
| Granuloma | 1 | 2023 | 61 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 316 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2021 | 3835 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2023 | 289 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2026 | 8553 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 868 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4664 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2023 | 180 | 0.040 |
Why?
|
| Pyroptosis | 1 | 2021 | 35 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 517 | 0.040 |
Why?
|
| Female | 5 | 2026 | 70509 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2025 | 767 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2019 | 31 | 0.040 |
Why?
|
| Hepcidins | 1 | 2019 | 27 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 230 | 0.040 |
Why?
|
| Multivesicular Bodies | 1 | 2018 | 2 | 0.040 |
Why?
|
| Exercise | 1 | 2024 | 866 | 0.040 |
Why?
|
| Ferritins | 1 | 2019 | 108 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 369 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 28 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 63 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 106 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1843 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 82 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 237 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 461 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 495 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 239 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2018 | 175 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 569 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 722 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2019 | 414 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 256 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2026 | 17653 | 0.030 |
Why?
|
| Biomarkers | 1 | 2026 | 3397 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1509 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1489 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1849 | 0.020 |
Why?
|
| Infant | 1 | 2026 | 13306 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 9991 | 0.020 |
Why?
|
| Male | 2 | 2026 | 64557 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 14987 | 0.020 |
Why?
|